drugset
drugset / Trial / NCT00591331

Phototoxicity Potential of NatrOVA Creme Rinse - 1%

NCT00591331 ↗

Phase 1 Completed 37 enrolled ParaPRO LLC
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the primary irritation potential of NatrOVA Creme Rinse - 1% in humans, after exposure to UV radiation.

Timeline

Start
2007-12
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Spinosad Small molecule 1 % Topical

Indications

Pediculus humanus capitis infestation